Common Name |
Antipyrine
Description |
An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Synonyms |
Value |
Source |
1,2-dihydro-1,5-Dimethyl-2-phenyl-3H-pyrazol-3-oneChEBI
2,3-Dimethyl-1-phenyl-5-pyrazoloneChEBI
FenazonaChEBI
PhenazoneChEBI
AnalgesineHMDB
AnodyninHMDB
AnodynineHMDB
AntipirinHMDB
AntipyrinHMDB
AntipyrinumHMDB
AzophenHMDB
AzophenumHMDB
FenazoneHMDB
PhenozoneHMDB
PyramidoneMeSH
Chemical Formlia |
C11H12N2O
Average Molecliar Weight |
188.2258
Monoisotopic Molecliar Weight |
188.094963016
IUPAC Name |
1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one
Traditional Name |
antipyrine
CAS Registry Number |
60-80-0
SMILES |
CN1N(C(=O)C=C1C)C1=CC=CC=C1
InChI Identifier |
InChI=1S/C11H12N2O/c1-9-8-11(14)13(12(9)2)10-6-4-3-5-7-10/h3-8H,1-2H3
InChI Key |
VEQOALNAAJBPNY-UHFFFAOYSA-N
Chemical Taxonomy |
Description |
This compound belongs to the class of chemical entities known as phenylpyrazoles. These are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group.
Kingdom |
Chemical entities
Super Class |
Organic compounds
Class |
Organoheterocyclic compounds
Sub Class |
Azoles
Direct Parent |
Phenylpyrazoles
Alternative Parents |
Pyrazolones
Benzene and substituted derivatives
Vinylogous amides
Heteroaromatic compounds
Lactams
Azacyclic compounds
Organopnictogen compounds
Organooxygen compounds
Organonitrogen compounds
Organic oxides
Hydrocarbon derivatives
Substituents |
Phenylpyrazole
Monocyclic benzene moiety
Pyrazolinone
Benzenoid
Heteroaromatic compound
Vinylogous amide
Lactam
Azacycle
Organic nitrogen compound
Hydrocarbon derivative
Organic oxide
Organopnictogen compound
Organooxygen compound
Organonitrogen compound
Organic oxygen compound
Aromatic heteromonocyclic compound
Molecliar Framework |
Aromatic heteromonocyclic compounds
External Descriptors |
pyrazolone (CHEBI:31225 )
Ontology |
Status |
Expected but not Quantified
Origin |
Drug
Biofunction |
Not Available
Application |
Pharmaceutical
Cellliar locations |
Cytoplasm
Membrane
Physical Properties |
State |
Solid
Experimental Properties |
Property |
Value |
Reference |
Melting Point114 °CNot Available
Boiling PointNot AvailableNot Available
Water Solubility4.74e+01 g/LNot Available
LogP0.38HANSCH,C ET AL. (1995)
Predicted Properties |
Property |
Value |
Source |
Water Solubility47.4 mg/mLALOGPS
logP1.18ALOGPS
logP1.22ChemAxon
logS-0.6ALOGPS
pKa (Strongest Basic)0.37ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area23.55 Å2ChemAxon
Rotatable Bond Count1ChemAxon
Refractivity56.42 m3·mol-1ChemAxon
Polarizability20.4 Å3ChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
Spectra |
Spectra |
Spectrum Type |
Description |
Splash Key |
|
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-001a-0900000000-94d2c7fe629bedc897b3View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-000i-0900000000-ebc5f64904e52ff3d68eView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-000i-0900000000-602baaec0430c9c48fc7View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-000i-0900000000-a3fafbc8e8baf10dba96View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-000i-0900000000-ad19708445bbe9cd2bffView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-052s-2900000000-efb8c895ae384b102f76View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-0a4i-4900000000-80fc3f4f0ffbc6d8c8bbView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-000i-0900000000-3a2d3f4534b07f6de875View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-000i-0900000000-dbaaf801a6650b53331bView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-000i-0900000000-0258999e6a4bf7041deaView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-000i-0900000000-4b511d8866a35ece5abdView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-0a4s-2900000000-eea7fbb638b6e5146e90View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-0a4i-4900000000-80478740d36be900a6e7View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-01q1-0900000000-e6dcb2d1a0ca860186fbView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-000i-0900000000-ae7f87ba95e0fc52493eView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-1011-1900000000-a520cee151b2f2b6fcd1View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-000i-0900000000-4fe0a2e33ea5e0c5c876View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-01wb-0900000000-1eaec6590298997b716eView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-QTOF , positivesplash10-000i-0900000000-65a45a9258dc65cd80a4View in MoNA
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, NegativeNot Available
Biological Properties |
Cellliar Locations |
Cytoplasm
Membrane
Biofluid Locations |
Blood
Urine
Tissue Location |
Not Available
Pathways |
Name |
SMPDB Link |
KEGG Link |
Antipyrine Action PathwaySMP00692Not Available
Normal Concentrations |
Biofluid |
Status |
Age |
Condition |
Reference |
Details |
BloodExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB01435
21059682
details
UrineExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB01435
21059682
details
|
Abnormal Concentrations |
|
Not Available
Associated Disorders and Diseases |
Disease References |
None
Associated OMIM IDs |
None
External Links |
DrugBank ID |
DB01435
DrugBank Metabolite ID |
Not Available
Phenol Explorer Compound ID |
Not Available
Phenol Explorer Metabolite ID |
Not Available
FoodDB ID |
Not Available
KNApSAcK ID |
Not Available
Chemspider ID |
2121
KEGG Compound ID |
C13244
BioCyc ID |
Not Available
BiGG ID |
Not Available
Wikipedia Link |
Phenazone
NuGOwiki Link |
HMDB15503
Metagene Link |
HMDB15503
METLIN ID |
Not Available
PubChem Compound |
2206
PDB ID |
Not Available
ChEBI ID |
31225
Product: Tafamidis
References |
Synthesis Reference |
Not Available |
Material Safety Data Sheet (MSDS) |
Download (PDF) |
General References |
Not Available |
PMID: 26282097